ALTERITY THERAPEUTICS LTD (ATHE) Insider Trading

Name: ALTERITY THERAPEUTICS LTD (ATHE) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Sep 8, 2026): Marks Peter Ashley (Director): Purchase of 47,620 shares, $23.8K.

Get alerted when insiders trade ATHE

Email address

Loading company data...

Beta

Loading company details...

Beta